Abstract:Ochratoxin A (OTA) is one of the most abundant mycotoxin contaminants in food stuffs and possesses carcinogenic, nephrotoxic, teratogenic, and immunotoxic properties. Specifically, a major concern is severe nephrotoxicity, which is characterized by degeneration of epithelial cells of the proximal tubules and interstitial fibrosis. However, the mechanism of OTA toxicity, as well as the genetic risk factors contributing to its toxicity in humans has been elusive due to the lack of adequate models that fully recapitulate human kidney function in vitro. The present study attempts to evaluate dose-response relationships, identify the contribution of active transport proteins that govern the renal disposition of OTA, and determine the role of metabolism in the bioactivation and detoxification of OTA using a 3D human kidney proximal tubule microphysiological system (kidney MPS). We demonstrated that LC50 values of OTA in kidney MPS culture (0.375-1.21 μM) were in agreement with clinically relevant toxic concentrations of OTA in urine. Surprisingly, no enhancement of kidney injury biomarkers was evident in the effluent of the kidney MPS after OTA exposure despite significant toxicity observed by LIVE/DEAD staining. Instead, these biomarkers decreased in an OTA concentration-dependent manner. Furthermore, the effect of 1-aminobenzotriazole (ABT) and 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol (NBDHEX), pan-inhibitors of P450 and glutathione S-transferase (GST) enzymes, respectively, on OTA-induced toxicity in kidney MPS was examined. These studies revealed significant enhancement of OTA-induced toxicity by NBDHEX (3 μM) treatment, whereas ABT (1 mM) treatment decreased OTA-induced toxicity, suggesting roles for GSTs and P450 enzymes in the detoxification and bioactivation of OTA, respectively. Analysis of transcriptional changes using RNA-sequencing of kidney MPS treated with different concentrations of OTA revealed downregulation of several nuclear factor (erythroid derived-2)-like 2 (NRF2)-regulated genes by OTA treatment, including GSTs. The transcriptional repression of GSTs is likely playing a key role in OTA toxicity via attenuation of glutathione conjugation/detoxification. The sequential molecular events may explain the mechanism of toxicity associated with OTA. Additionally, OTA transport studies using kidney MPS in the presence and absence of probenecid (1 mM) suggested a role for organic anionic membrane transporter(s) in the kidney specific disposition of OTA. Our findings provide a clearer understanding of the mechanism of OTA-induced kidney injury, which may support changes in risk assessment, regulatory agency policies on allowable exposure levels, and determination of the role of genetic factors in populations at risk for OTA nephrotoxicity.

Ochratoxin A induces nephrotoxicity in vitro and in vivo via pyroptosis

Ochratoxin A induces NLRP3 inflammasome-mediated pyroptosis via activation of ROS modulated by autophagy in vitro

Ochratoxin A Induces Nephrotoxicity and Immunotoxicity Through Different MAPK Signaling Pathways in PK15 Cells and Porcine Primary Splenocytes.

Ochratoxin A induces glomerular injury through activating the ERK/NF-κB signaling pathway

Ochratoxin A Induces Apoptosis in Neuronal Cells

Ochratoxin A Induces Rat Renal Carcinogenicity with Limited Induction of Oxidative Stress Responses.

Microphysiological system modeling of ochratoxin A-associated nephrotoxicity

Ochratoxin A Induces Cytoprotective Autophagy Via Blocking AKT/mTOR Signaling Pathway in PK-15 Cells.

Taurine Alleviates Ochratoxin A‐induced Pyroptosis in PK‐15 Cells by Inhibiting Oxidative Stress

In vitro immune toxicity of ochratoxin A in porcine alveolar macrophages: A role for the ROS-relative TLR4/MyD88 signaling pathway

Toxicological and physiological effects of successive exposure to ochratoxin A at food regulatory limits

Nontoxic Concentration of Ochratoxin A Aggravates Renal Fibrosis Induced by Adriamycin/Cyclosporine A Nephropathy Via TGF-β1/SMAD2/3

Nephrotoxicity Instead of Immunotoxicity of OTA is Induced Through DNMT1-dependent Activation of JAK2/STAT3 Signaling Pathway by Targeting SOCS3

Regulation of Taurine in OTA-induced Apoptosis and Autophagy.

Non-cytotoxic Dosage of Fumonisin B1 Aggravates Ochratoxin A-induced Nephrocytotoxicity and Apoptosis Via ROS-dependent JNK/MAPK Signaling Pathway

In vitro and in vivo induction of ochratoxin a exposure-related micronucleus formation in rat proximal tubular epithelial cells and expression profiling of chromosomal instability-related genes

EGCG alleviates Ochratoxin A-induced pyroptosis in rat's kidney by inhibiting NLRP3/Caspase-1/GSDMD signaling pathway

Ochratoxin A Induced Differentiation Nephrotoxicity in Renal Tubule and Glomeruli Via Autophagy Differential Regulation

Limited Link Between Oxidative Stress and Ochratoxin A-Induced Renal Injury in an Acute Toxicity Rat Model.

Central role of Sigma-1 receptor in ochratoxin A-induced ferroptosis

Ochratoxin A Induces Renal Cell Ferroptosis by Disrupting Iron Homeostasis and Increasing ROS